Back
ESC Professional Premium Access

Analytical approaches to open label extension (OLE) after cardiovascular outocmes trials: Observations from the FOURIER and FOURIER-OLE trials

Session: Drug therapy (2)
Topic: Drug therapy
Speaker: Miss H. Wang (Newbury Park, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Miss Huei Wang

Newbury Park (United States of America)
0 follower

6 more presentations in this session

Bempedoic acid in clinical practice.

Speaker: Doctor J. Vazquez Reguera (Las Palmas de Gran Canaria, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Association of lipid-lowering drug treatment with all-cause and cardiovascular mortality among people aged 75 years and above without cardiovascular disease: evidence from a cohort study

Speaker: Assistant Professor Z. Yang (Shatin, HK)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy and safety of Alirocumab once-monthly dosing in patients with atherosclerotic cardiovascular disease and without acute coronary syndrome or stroke; an ODYSSEY CHOICE I analysis

Speaker: Doctor C. Bonanad Lozano (Valencia, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

LDL on target - strike early and strike strong... just strike...

Speaker: Doctor L. Hamann (Faro, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

VICTORION IMPLEMENT: an observational study of the lipid management landscape in Germany

Speaker: Professor O. Weingaertner (Jena, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Drug therapy (2)

Speakers: Miss H. Wang, Doctor J. Vazquez Reguera, Assistant Professor Z. Yang, Doctor C. Bonanad Lozano, Doctor L. Hamann...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources